Semaglutide Dosing Schedule: Complete Week-by-Week Guide

## Semaglutide Titration: Why the Weekly Schedule Matters Roughly 1 in 5 patients who discontinue semaglutide do so because of ## The Standard Semaglutide Dosing Protocol Semaglutide is a once-weekly [subcutaneous injection](/guides/how-to-inject-semaglutide-step-by-step-guide). The FDA-approved titration follows a stepwise increase every 4 weeks, and there are good clinical reasons behind each phase.

Phase	Weeks	Dose	Purpose
Adaptation	1-4	0.25mg	GI system adjustment, sub-therapeutic
First Escalation	5-8	0.5mg	Therapeutic appetite suppression begins
Intermediate	9-12	1.0mg	Full metabolic effect, significant weight loss
Advanced	13-16	1.7mg	Enhanced efficacy for higher BMI patients
Maximum	17+	2.4mg	Maximum approved maintenance dose

### Weeks 1-4: The Adaptation Phase (0.25mg) Think of this as the handshake between semaglutide and your GLP-1 receptors. The 0.25mg starting dose is sub-therapeutic for weight loss on purpose. Its job is to let your gastrointestinal system adjust to delayed gastric emptying and increased satiety signaling. During this phase, most patients notice: - Subtle changes in appetite, often described as "just not thinking about food as much" - Mild nausea in about 20% of people, usually worst in the first 48 hours after injection - Minimal weight change (0-2 lbs is typical and completely normal) **A practical tip from our clinical team:** Pick your [injection day](/guides/semaglutide-injection-sites-abdomen-thigh-arm) based on your schedule, not the calendar. If weekends are when you socialize and eat out, injecting on Monday means any mild nausea hits mid-week when you are in a controlled routine. Many of our patients prefer Sunday evening so they sleep through the initial adjustment window. ### Weeks 5-8: First Dose Escalation (0.5mg) This is where the medication starts pulling its weight. At 0.5mg, GLP-1 receptor activation reaches therapeutic levels for appetite suppression, and most patients begin to notice real changes in their relationship with food. What to realistically expect: - Portion sizes naturally shrink. You may find yourself leaving food on your plate without thinking about it. - Weight loss of 2-4 lbs over the 4-week period is typical, though individual results vary widely. - GI side effects may temporarily flare when you step up. This usually resolves within 5-7 days. The STEP 5 two-year extension study (Nature Medicine, 2022) showed that patients who tolerated the 0.5mg phase well had an 89% likelihood of completing the full titration to their target dose. ### Weeks 9-12: Second Escalation (1mg) For many patients, 1mg is the inflection point. This is the dose where the SUSTAIN and STEP trials began to show statistically significant separation from placebo in both weight and metabolic outcomes. At this dose, you will likely experience: - Meaningful appetite suppression that feels effortless rather than forced - Accelerated fat loss, particularly visceral fat around the abdomen - Reduced food noise, meaning fewer intrusive thoughts about eating between meals - Measurable improvements in fasting glucose and HbA1c for those with insulin resistance We recommend that patients at this phase start prioritizing protein intake (aim for 0.7-1g per pound of lean body mass daily) and begin or maintain a resistance training program. The weight you lose should be predominantly fat, not muscle. ### Weeks 13-16: Third Escalation (1.7mg) Not everyone needs to go beyond 1mg. In fact, the STEP 4 trial (JAMA, 2021) demonstrated that continuing semaglutide at any effective dose was far more important than reaching the [maximum dose](/guides/semaglutide-high-dose-1-7mg-2-4mg-guide). If you are losing 1-2 lbs per week at 1mg and feeling good, talk to your provider about staying there. That said, the 1.7mg dose is appropriate when: - Weight loss has stalled for 3-4 consecutive weeks despite dietary compliance - Your provider has confirmed that the plateau is not related to other factors (fluid retention, medication interactions, hormonal shifts) - You tolerated 1mg without significant GI symptoms ### Weeks 17+: Maximum Dose (2.4mg) The 2.4mg dose is the ceiling approved by the FDA for chronic weight management. In the STEP 1 trial, participants at this dose achieved an average [weight loss of 14.9% of body weight](/guides/semaglutide-weight-loss-results-timeline-what-to-expect) at 68 weeks, with some individuals exceeding 20%. Important context: roughly 30-40% of patients in clinical trials achieved their weight loss goals at doses below 2.4mg and never needed to reach the maximum. More is not always better. The right dose is the lowest dose that produces consistent, tolerable results for you. ## When to Slow Down or Pause Dose Escalation One of the most common mistakes we see is rigid adherence to the 4-week escalation timeline regardless of how the patient is doing. The schedule is a guideline, not a mandate. Consider staying at your current dose for an additional 2-4 weeks if: - Nausea persists beyond the first week after a dose increase and is not improving - You are experiencing vomiting more than once per week - Significant abdominal discomfort or bloating is interfering with daily activities - You are already losing weight at a healthy pace (1-2 lbs per week) Your clinician may also recommend a slower escalation if you have a history of gastroparesis, gallbladder disease, or are taking other medications that affect GI motility. ## Practical Guidance for Each Phase ### Nutrition During Titration The reduced appetite semaglutide produces is powerful, but it can work against you if it leads to under-eating. Severely restricting calories while on semaglutide can cause muscle loss, nutritional deficiencies, and paradoxically slow your metabolism. We recommend: 1. **Target 60-80g of protein daily at minimum.** Lean meats, eggs, Greek yogurt, and legumes are your allies. For more details, see our [GLP-1 diet guide](/guides/what-to-eat-on-glp1-medications-diet-guide). 2. **Eat smaller, more frequent meals** rather than forcing three large ones. Your gastric emptying is slower, so large meals will sit uncomfortably. 3. **Stay well-hydrated.** Aim for 8-10 glasses of water daily. Dehydration worsens nausea and constipation. 4. **Limit greasy and heavily spiced foods** during the first 2 weeks of each dose increase, when GI sensitivity peaks. ### How to Know You Are Ready for the Next Dose Your body gives clear signals. Look for: - GI side effects from the current dose have fully resolved - Appetite suppression is noticeably weaker than it was 2-3 weeks ago - Weight loss has slowed to less than 0.5 lbs per week for 2+ consecutive weeks - Your provider has reviewed your labs and overall progress ## Weight Loss Expectations by Dose | Dose | Typical Monthly Weight Loss | What Most Patients Report | |------|----------------------------|-----------------------------| | 0.25mg | 0-2 lbs | "I notice I get full faster, but not much else yet" | | 0.5mg | 2-5 lbs | "I am eating less without really trying" | | 1mg | 4-8 lbs | "Food noise is almost gone. Cravings are manageable" | | 1.7mg | 5-10 lbs | "My eating habits have fundamentally changed" | | 2.4mg | 6-12 lbs | "Appetite is well-controlled, steady progress" | *These ranges reflect typical clinical experience. Individual results depend on diet, activity level, starting weight, metabolic health, and adherence.* ## Key Reminders - **Never double up** if you [miss a dose](/guides/what-happens-if-you-miss-a-semaglutide-dose). If your next scheduled dose is more than 2 days away, take it as soon as you remember. Otherwise, skip and resume your normal schedule. - **Inject on the same day each week** to maintain steady drug levels. Semaglutide has a half-life of approximately 7 days. - **[Rotate injection sites](/guides/semaglutide-injection-sites-abdomen-thigh-arm)** between the abdomen, thigh, and upper arm to avoid lipodystrophy. - **Keep every follow-up appointment.** Dose titration decisions should always involve your prescriber. The patients who do best on semaglutide are not the ones who rush to the highest dose. They are the ones who listen to their body, communicate openly with their provider, and treat the titration schedule as a process rather than a race. --- ## References - [Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183). *New England Journal of Medicine*, 2021. - [Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5)](https://www.nature.com/articles/s41591-022-02026-4). *Nature Medicine*, 2022. - [Wegovy (semaglutide) Prescribing Information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf). *U.S. FDA*, 2023. - [Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4)](https://jamanetwork.com/journals/jama/fullarticle/2777886). *JAMA*, 2021. - [Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6)](https://www.nejm.org/doi/full/10.1056/NEJMoa1607141). *New England Journal of Medicine*, 2016.